Share Price and Basic Stock Data
Last Updated: November 8, 2025, 5:39 am
| PEG Ratio | 0.52 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Alankit Ltd operates within the Finance & Investments sector, with its stock currently priced at ₹12.00 and a market capitalization of ₹327 Cr. The company has shown a varied revenue trajectory over the past years. Sales stood at ₹312 Cr for the year ending March 2023, down from ₹236 Cr in March 2024, but rebounded to ₹301 Cr in March 2025. The trailing twelve months (TTM) revenue is reported at ₹330 Cr. Quarterly sales figures present a fluctuating pattern, with the highest recorded at ₹148.18 Cr in March 2023, followed by a decline to ₹43.32 Cr in September 2023. This volatility in revenue reflects potential challenges in maintaining consistent demand or operational efficiency. The company’s operating profit margin (OPM) was negative at -5.01% for the latest quarter, indicating ongoing struggles in managing costs relative to sales, which could hinder long-term growth prospects.
Profitability and Efficiency Metrics
Profitability indicators for Alankit Ltd reveal a complex picture. The company reported a net profit of ₹20 Cr, translating to an earnings per share (EPS) of ₹0.73 for March 2025. However, the recent quarterly performance shows declines, with a net profit of only ₹2.54 Cr in September 2023. The return on equity (ROE) is recorded at 7.56%, while the return on capital employed (ROCE) stands at 11.3%, both of which are below desirable industry benchmarks. The interest coverage ratio (ICR) is strong at 13.34x, suggesting the company can comfortably meet its interest obligations, a positive sign for creditors. However, the negative OPM of -5.01% indicates that operational efficiency needs significant improvement, as costs are currently outpacing revenues. Overall, while profitability metrics indicate potential, the efficiency ratios reflect challenges that could hinder sustainable growth.
Balance Sheet Strength and Financial Ratios
Alankit Ltd’s balance sheet exhibits a mix of strengths and weaknesses. The company holds reserves of ₹270 Cr against borrowings of only ₹12 Cr, indicating a robust liquidity position with a debt-to-equity ratio of 0.03, significantly lower than typical sector averages. This conservative leverage provides a cushion against financial distress. However, the company’s total assets reported at ₹425 Cr against total liabilities of ₹531 Cr suggest a concerning trend of increasing liabilities, which could impact financial stability. The current ratio is strong at 2.16, indicating good short-term liquidity, while the quick ratio is also favorable at 2.08. Additionally, the book value per share stands at ₹10.94, further showcasing asset strength. However, as the company continues to experience fluctuations in profitability, it must address the growing liabilities to enhance overall financial health.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Alankit Ltd reflects a stable yet cautious investor sentiment. Promoters hold a majority stake of 54.14%, providing a degree of control and stability. However, foreign institutional investors (FIIs) and domestic institutional investors (DIIs) have minimal stakes at 0.38% and 0.01%, respectively, indicating limited confidence from institutional investors. The public holds 45.46%, with the number of shareholders rising to 116,798, which may suggest growing retail interest. Despite the increase in public shareholders, the low institutional participation could be a concern for long-term growth, as institutional investors often bring stability and confidence to the stock. Overall, while the promoter holding provides some assurance, the low institutional presence may impact the company’s market perception and investor confidence.
Outlook, Risks, and Final Insight
The outlook for Alankit Ltd presents both opportunities and risks. On one hand, the strong liquidity position and low debt levels are significant strengths that enable the company to navigate financial challenges effectively. However, the ongoing volatility in revenue and profitability, highlighted by the negative operating profit margin, poses a substantial risk. Additionally, the rising total liabilities compared to assets could lead to liquidity issues if not managed carefully. The company’s ability to stabilize its revenue streams and improve operational efficiency will be crucial for future growth. If Alankit Ltd can successfully implement strategies to enhance its operational performance and attract institutional investors, it may achieve a more favorable market position. Conversely, failure to address these challenges could hinder its growth trajectory and investor confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Alankit Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 12.6 Cr. | 43.0 | 67.7/36.4 | 50.4 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,425 Cr. | 305 | 488/280 | 15.7 | 102 | 0.33 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 37.3 Cr. | 0.53 | 2.42/0.46 | 3.62 | 0.02 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 4.14 Cr. | 8.36 | 12.6/8.25 | 10.3 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 30.3 Cr. | 58.9 | 72.0/47.6 | 20.6 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 6,983.19 Cr | 1,374.58 | 108.16 | 3,835.00 | 0.32% | 21.70% | 14.20% | 7.28 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 34.22 | 13.19 | 116.10 | 148.18 | 48.62 | 43.32 | 52.61 | 91.16 | 61.93 | 64.35 | 72.77 | 102.01 | 90.78 |
| Expenses | 27.02 | 27.86 | 105.15 | 139.92 | 43.26 | 38.70 | 49.05 | 80.79 | 53.72 | 58.94 | 66.14 | 89.53 | 95.33 |
| Operating Profit | 7.20 | -14.67 | 10.95 | 8.26 | 5.36 | 4.62 | 3.56 | 10.37 | 8.21 | 5.41 | 6.63 | 12.48 | -4.55 |
| OPM % | 21.04% | -111.22% | 9.43% | 5.57% | 11.02% | 10.66% | 6.77% | 11.38% | 13.26% | 8.41% | 9.11% | 12.23% | -5.01% |
| Other Income | 1.58 | -36.85 | -6.81 | 2.08 | 2.45 | 2.47 | 5.76 | 1.16 | 3.11 | 3.85 | 1.95 | 3.52 | 16.93 |
| Interest | 0.48 | 0.49 | 0.52 | 0.13 | 0.25 | 0.60 | 0.56 | -0.29 | 0.86 | 0.95 | 0.97 | 1.05 | 0.59 |
| Depreciation | 2.13 | 1.90 | 1.97 | 2.47 | 1.94 | 1.91 | 1.88 | 1.94 | 1.90 | 2.16 | 2.77 | 3.56 | 3.27 |
| Profit before tax | 6.17 | -53.91 | 1.65 | 7.74 | 5.62 | 4.58 | 6.88 | 9.88 | 8.56 | 6.15 | 4.84 | 11.39 | 8.52 |
| Tax % | 24.64% | -7.81% | -161.21% | 27.52% | 13.70% | 44.54% | -18.02% | 34.62% | 12.03% | 40.49% | -7.44% | 53.73% | 30.05% |
| Net Profit | 4.65 | -49.69 | 4.31 | 5.60 | 4.85 | 2.54 | 8.12 | 6.47 | 7.53 | 3.67 | 5.20 | 5.27 | 5.96 |
| EPS in Rs | 0.31 | -3.24 | 0.24 | 0.21 | 0.21 | 0.09 | 0.36 | 0.24 | 0.27 | 0.12 | 0.19 | 0.16 | 0.19 |
Last Updated: August 20, 2025, 2:05 pm
Below is a detailed analysis of the quarterly data for Alankit Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 90.78 Cr.. The value appears to be declining and may need further review. It has decreased from 102.01 Cr. (Mar 2025) to 90.78 Cr., marking a decrease of 11.23 Cr..
- For Expenses, as of Jun 2025, the value is 95.33 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 89.53 Cr. (Mar 2025) to 95.33 Cr., marking an increase of 5.80 Cr..
- For Operating Profit, as of Jun 2025, the value is -4.55 Cr.. The value appears to be declining and may need further review. It has decreased from 12.48 Cr. (Mar 2025) to -4.55 Cr., marking a decrease of 17.03 Cr..
- For OPM %, as of Jun 2025, the value is -5.01%. The value appears to be declining and may need further review. It has decreased from 12.23% (Mar 2025) to -5.01%, marking a decrease of 17.24%.
- For Other Income, as of Jun 2025, the value is 16.93 Cr.. The value appears strong and on an upward trend. It has increased from 3.52 Cr. (Mar 2025) to 16.93 Cr., marking an increase of 13.41 Cr..
- For Interest, as of Jun 2025, the value is 0.59 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.05 Cr. (Mar 2025) to 0.59 Cr., marking a decrease of 0.46 Cr..
- For Depreciation, as of Jun 2025, the value is 3.27 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.56 Cr. (Mar 2025) to 3.27 Cr., marking a decrease of 0.29 Cr..
- For Profit before tax, as of Jun 2025, the value is 8.52 Cr.. The value appears to be declining and may need further review. It has decreased from 11.39 Cr. (Mar 2025) to 8.52 Cr., marking a decrease of 2.87 Cr..
- For Tax %, as of Jun 2025, the value is 30.05%. The value appears to be improving (decreasing) as expected. It has decreased from 53.73% (Mar 2025) to 30.05%, marking a decrease of 23.68%.
- For Net Profit, as of Jun 2025, the value is 5.96 Cr.. The value appears strong and on an upward trend. It has increased from 5.27 Cr. (Mar 2025) to 5.96 Cr., marking an increase of 0.69 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.19. The value appears strong and on an upward trend. It has increased from 0.16 (Mar 2025) to 0.19, marking an increase of 0.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 22, 2025, 5:20 pm
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3 | 31 | 85 | 105 | 130 | 156 | 115 | 128 | 312 | 236 | 301 | 330 |
| Expenses | 3 | 22 | 64 | 76 | 110 | 132 | 96 | 117 | 299 | 210 | 268 | 310 |
| Operating Profit | -1 | 9 | 21 | 29 | 21 | 24 | 19 | 11 | 13 | 26 | 33 | 20 |
| OPM % | -27% | 28% | 25% | 28% | 16% | 15% | 17% | 9% | 4% | 11% | 11% | 6% |
| Other Income | 2 | 0 | 2 | 4 | 8 | 7 | 3 | 9 | -40 | 12 | 12 | 26 |
| Interest | 0 | 0 | 1 | 3 | 2 | 3 | 4 | 3 | 2 | 3 | 4 | 4 |
| Depreciation | 0 | 3 | 1 | 4 | 4 | 5 | 4 | 9 | 8 | 8 | 10 | 12 |
| Profit before tax | 1 | 5 | 20 | 26 | 22 | 23 | 15 | 8 | -38 | 27 | 31 | 31 |
| Tax % | 64% | 29% | 35% | 16% | 35% | 38% | 24% | 66% | -8% | 19% | 30% | |
| Net Profit | 0 | 4 | 13 | 22 | 14 | 14 | 11 | 3 | -35 | 22 | 22 | 20 |
| EPS in Rs | 0.03 | 0.26 | 0.93 | 1.52 | 0.98 | 0.98 | 0.69 | 0.17 | -1.50 | 0.80 | 0.73 | 0.66 |
| Dividend Payout % | 193% | 39% | 22% | 13% | 20% | 20% | 29% | 121% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 225.00% | 69.23% | -36.36% | 0.00% | -21.43% | -72.73% | -1266.67% | 162.86% | 0.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -155.77% | -105.59% | 36.36% | -21.43% | -51.30% | -1193.94% | 1429.52% | -162.86% |
Alankit Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 61% |
| 5 Years: | 14% |
| 3 Years: | 33% |
| TTM: | 32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 52% |
| 5 Years: | 12% |
| 3 Years: | 110% |
| TTM: | -18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -6% |
| 3 Years: | 1% |
| 1 Year: | -46% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 9% |
| 3 Years: | 10% |
| Last Year: | 8% |
Last Updated: September 4, 2025, 10:40 pm
Balance Sheet
Last Updated: August 11, 2025, 4:26 pm
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 14 | 14 | 14 | 14 | 14 | 14 | 22 | 27 | 27 |
| Reserves | 24 | 28 | 33 | 49 | 59 | 73 | 80 | 119 | 139 | 249 | 270 |
| Borrowings | 0 | 0 | 5 | 5 | 14 | 13 | 14 | 21 | 13 | 44 | 12 |
| Other Liabilities | 1 | 16 | 26 | 58 | 53 | 71 | 57 | 107 | 128 | 211 | 116 |
| Total Liabilities | 33 | 51 | 78 | 126 | 140 | 172 | 165 | 261 | 302 | 531 | 425 |
| Fixed Assets | 1 | 28 | 28 | 36 | 55 | 50 | 68 | 87 | 56 | 50 | 81 |
| CWIP | 0 | 0 | 0 | 18 | 16 | 18 | 1 | 0 | 0 | 9 | 0 |
| Investments | 1 | 0 | 2 | 1 | 1 | 0 | 1 | 12 | 11 | 21 | 36 |
| Other Assets | 30 | 23 | 49 | 70 | 68 | 104 | 97 | 161 | 236 | 451 | 308 |
| Total Assets | 33 | 51 | 78 | 126 | 140 | 172 | 165 | 261 | 302 | 531 | 425 |
Below is a detailed analysis of the balance sheet data for Alankit Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 27.00 Cr..
- For Reserves, as of Mar 2025, the value is 270.00 Cr.. The value appears strong and on an upward trend. It has increased from 249.00 Cr. (Mar 2024) to 270.00 Cr., marking an increase of 21.00 Cr..
- For Borrowings, as of Mar 2025, the value is 12.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 44.00 Cr. (Mar 2024) to 12.00 Cr., marking a decrease of 32.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 116.00 Cr.. The value appears to be improving (decreasing). It has decreased from 211.00 Cr. (Mar 2024) to 116.00 Cr., marking a decrease of 95.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 425.00 Cr.. The value appears to be improving (decreasing). It has decreased from 531.00 Cr. (Mar 2024) to 425.00 Cr., marking a decrease of 106.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 81.00 Cr.. The value appears strong and on an upward trend. It has increased from 50.00 Cr. (Mar 2024) to 81.00 Cr., marking an increase of 31.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 9.00 Cr..
- For Investments, as of Mar 2025, the value is 36.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Mar 2024) to 36.00 Cr., marking an increase of 15.00 Cr..
- For Other Assets, as of Mar 2025, the value is 308.00 Cr.. The value appears to be declining and may need further review. It has decreased from 451.00 Cr. (Mar 2024) to 308.00 Cr., marking a decrease of 143.00 Cr..
- For Total Assets, as of Mar 2025, the value is 425.00 Cr.. The value appears to be declining and may need further review. It has decreased from 531.00 Cr. (Mar 2024) to 425.00 Cr., marking a decrease of 106.00 Cr..
Notably, the Reserves (270.00 Cr.) exceed the Borrowings (12.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -1.00 | 9.00 | 16.00 | 24.00 | 7.00 | 11.00 | 5.00 | -10.00 | 0.00 | -18.00 | 21.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 106 | 69 | 54 | 49 | 78 | 89 | 110 | 131 | 80 | 111 | 72 |
| Inventory Days | 1,297 | 247 | 76 | 142 | 288 | 57 | 119 | 62 | 9 | 31 | 19 |
| Days Payable | 288 | 59 | 92 | 1,274 | 561 | 274 | 316 | 221 | 47 | 153 | 56 |
| Cash Conversion Cycle | 1,114 | 257 | 38 | -1,083 | -196 | -129 | -88 | -28 | 41 | -10 | 35 |
| Working Capital Days | 2,506 | 91 | 26 | 4 | 27 | 86 | 147 | 14 | 105 | -54 | 77 |
| ROCE % | 16% | 50% | 47% | 30% | 24% | 17% | 8% | 8% | 11% | 11% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 0.73 | 0.96 | -2.07 | 0.16 | 0.77 |
| Diluted EPS (Rs.) | 0.73 | 0.96 | -2.07 | 0.16 | 0.77 |
| Cash EPS (Rs.) | 1.18 | 1.09 | -1.19 | 0.80 | 1.08 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 10.94 | 10.95 | 8.07 | 10.12 | 6.88 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 10.94 | 10.95 | 8.07 | 10.12 | 6.88 |
| Revenue From Operations / Share (Rs.) | 11.10 | 8.69 | 13.88 | 8.96 | 8.04 |
| PBDIT / Share (Rs.) | 1.88 | 1.32 | 0.97 | 1.31 | 1.44 |
| PBIT / Share (Rs.) | 1.50 | 1.04 | 0.59 | 0.69 | 1.13 |
| PBT / Share (Rs.) | 1.14 | 0.99 | -1.71 | 0.58 | 1.02 |
| Net Profit / Share (Rs.) | 0.79 | 0.81 | -1.56 | 0.20 | 0.77 |
| NP After MI And SOA / Share (Rs.) | 0.73 | 0.79 | -1.50 | 0.16 | 0.77 |
| PBDIT Margin (%) | 16.96 | 15.17 | 7.00 | 14.56 | 17.91 |
| PBIT Margin (%) | 13.51 | 11.91 | 4.28 | 7.76 | 14.09 |
| PBT Margin (%) | 10.27 | 11.43 | -12.30 | 6.55 | 12.67 |
| Net Profit Margin (%) | 7.19 | 9.32 | -11.26 | 2.24 | 9.62 |
| NP After MI And SOA Margin (%) | 6.59 | 9.14 | -10.82 | 1.83 | 9.62 |
| Return on Networth / Equity (%) | 6.69 | 7.80 | -20.95 | 1.76 | 11.74 |
| Return on Capital Employeed (%) | 12.37 | 9.17 | 6.67 | 5.84 | 12.60 |
| Return On Assets (%) | 4.67 | 4.05 | -11.16 | 0.90 | 6.69 |
| Long Term Debt / Equity (X) | 0.01 | 0.02 | 0.04 | 0.05 | 0.09 |
| Total Debt / Equity (X) | 0.03 | 0.15 | 0.08 | 0.15 | 0.14 |
| Asset Turnover Ratio (%) | 0.63 | 0.56 | 1.11 | 0.60 | 0.68 |
| Current Ratio (X) | 2.16 | 1.16 | 2.09 | 1.37 | 2.46 |
| Quick Ratio (X) | 2.08 | 1.13 | 2.04 | 1.26 | 2.34 |
| Inventory Turnover Ratio (X) | 42.21 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 121.32 | 25.81 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 25.84 | 18.48 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | -21.32 | 74.19 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 74.16 | 81.52 |
| Interest Coverage Ratio (X) | 13.34 | 31.83 | 13.43 | 11.95 | 12.61 |
| Interest Coverage Ratio (Post Tax) (X) | 8.21 | 20.57 | 10.20 | 2.84 | 7.78 |
| Enterprise Value (Cr.) | 379.17 | 477.53 | 180.29 | 198.90 | 237.14 |
| EV / Net Operating Revenue (X) | 1.26 | 2.03 | 0.57 | 1.55 | 2.06 |
| EV / EBITDA (X) | 7.42 | 13.35 | 8.26 | 10.66 | 11.51 |
| MarketCap / Net Operating Revenue (X) | 1.25 | 2.04 | 0.52 | 1.47 | 1.97 |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | -21.32 | 74.18 |
| Price / BV (X) | 1.26 | 1.74 | 1.02 | 1.42 | 2.40 |
| Price / Net Operating Revenue (X) | 1.25 | 2.04 | 0.52 | 1.47 | 1.97 |
| EarningsYield | 0.05 | 0.04 | -0.20 | 0.01 | 0.04 |
After reviewing the key financial ratios for Alankit Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 5. It has decreased from 0.96 (Mar 24) to 0.73, marking a decrease of 0.23.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 5. It has decreased from 0.96 (Mar 24) to 0.73, marking a decrease of 0.23.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.18. This value is below the healthy minimum of 3. It has increased from 1.09 (Mar 24) to 1.18, marking an increase of 0.09.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 10.94. It has decreased from 10.95 (Mar 24) to 10.94, marking a decrease of 0.01.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 10.94. It has decreased from 10.95 (Mar 24) to 10.94, marking a decrease of 0.01.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 11.10. It has increased from 8.69 (Mar 24) to 11.10, marking an increase of 2.41.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.88. This value is below the healthy minimum of 2. It has increased from 1.32 (Mar 24) to 1.88, marking an increase of 0.56.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.50. This value is within the healthy range. It has increased from 1.04 (Mar 24) to 1.50, marking an increase of 0.46.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.14. This value is within the healthy range. It has increased from 0.99 (Mar 24) to 1.14, marking an increase of 0.15.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 2. It has decreased from 0.81 (Mar 24) to 0.79, marking a decrease of 0.02.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 2. It has decreased from 0.79 (Mar 24) to 0.73, marking a decrease of 0.06.
- For PBDIT Margin (%), as of Mar 25, the value is 16.96. This value is within the healthy range. It has increased from 15.17 (Mar 24) to 16.96, marking an increase of 1.79.
- For PBIT Margin (%), as of Mar 25, the value is 13.51. This value is within the healthy range. It has increased from 11.91 (Mar 24) to 13.51, marking an increase of 1.60.
- For PBT Margin (%), as of Mar 25, the value is 10.27. This value is within the healthy range. It has decreased from 11.43 (Mar 24) to 10.27, marking a decrease of 1.16.
- For Net Profit Margin (%), as of Mar 25, the value is 7.19. This value is within the healthy range. It has decreased from 9.32 (Mar 24) to 7.19, marking a decrease of 2.13.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.59. This value is below the healthy minimum of 8. It has decreased from 9.14 (Mar 24) to 6.59, marking a decrease of 2.55.
- For Return on Networth / Equity (%), as of Mar 25, the value is 6.69. This value is below the healthy minimum of 15. It has decreased from 7.80 (Mar 24) to 6.69, marking a decrease of 1.11.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.37. This value is within the healthy range. It has increased from 9.17 (Mar 24) to 12.37, marking an increase of 3.20.
- For Return On Assets (%), as of Mar 25, the value is 4.67. This value is below the healthy minimum of 5. It has increased from 4.05 (Mar 24) to 4.67, marking an increase of 0.62.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.03. This value is within the healthy range. It has decreased from 0.15 (Mar 24) to 0.03, marking a decrease of 0.12.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.63. It has increased from 0.56 (Mar 24) to 0.63, marking an increase of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 2.16. This value is within the healthy range. It has increased from 1.16 (Mar 24) to 2.16, marking an increase of 1.00.
- For Quick Ratio (X), as of Mar 25, the value is 2.08. This value exceeds the healthy maximum of 2. It has increased from 1.13 (Mar 24) to 2.08, marking an increase of 0.95.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 42.21. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 42.21, marking an increase of 42.21.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 13.34. This value is within the healthy range. It has decreased from 31.83 (Mar 24) to 13.34, marking a decrease of 18.49.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 8.21. This value is within the healthy range. It has decreased from 20.57 (Mar 24) to 8.21, marking a decrease of 12.36.
- For Enterprise Value (Cr.), as of Mar 25, the value is 379.17. It has decreased from 477.53 (Mar 24) to 379.17, marking a decrease of 98.36.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 2.03 (Mar 24) to 1.26, marking a decrease of 0.77.
- For EV / EBITDA (X), as of Mar 25, the value is 7.42. This value is within the healthy range. It has decreased from 13.35 (Mar 24) to 7.42, marking a decrease of 5.93.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.25. This value is within the healthy range. It has decreased from 2.04 (Mar 24) to 1.25, marking a decrease of 0.79.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / BV (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.74 (Mar 24) to 1.26, marking a decrease of 0.48.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.25. This value is within the healthy range. It has decreased from 2.04 (Mar 24) to 1.25, marking a decrease of 0.79.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alankit Ltd:
- Net Profit Margin: 7.19%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.37% (Industry Average ROCE: 21.4%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.69% (Industry Average ROE: 13.12%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 8.21
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.08
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 16.1 (Industry average Stock P/E: 75.86)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.03
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.19%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | 205-208, Anarkali Complex, New Delhi Delhi 110055 | investor@alankit.com http://www.alankit.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashok Kumar Sinha | Chairman & Ind.Director |
| Mr. Ankit Agarwal | Managing Director |
| Mrs. Preeti Chadha | Non Executive Director |
| Mrs. Meera Lal | Non Executive Director |
| Mr. Raja Gopal Reddy Guduru | Non Executive Director |
| Ms. Meenu Agrawal | Independent Director |
FAQ
What is the intrinsic value of Alankit Ltd?
Alankit Ltd's intrinsic value (as of 08 November 2025) is 10.83 which is 7.44% lower the current market price of 11.70, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 318 Cr. market cap, FY2025-2026 high/low of 25.6/10.5, reserves of ₹270 Cr, and liabilities of 425 Cr.
What is the Market Cap of Alankit Ltd?
The Market Cap of Alankit Ltd is 318 Cr..
What is the current Stock Price of Alankit Ltd as on 08 November 2025?
The current stock price of Alankit Ltd as on 08 November 2025 is 11.7.
What is the High / Low of Alankit Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Alankit Ltd stocks is 25.6/10.5.
What is the Stock P/E of Alankit Ltd?
The Stock P/E of Alankit Ltd is 16.1.
What is the Book Value of Alankit Ltd?
The Book Value of Alankit Ltd is 10.9.
What is the Dividend Yield of Alankit Ltd?
The Dividend Yield of Alankit Ltd is 0.00 %.
What is the ROCE of Alankit Ltd?
The ROCE of Alankit Ltd is 11.3 %.
What is the ROE of Alankit Ltd?
The ROE of Alankit Ltd is 7.56 %.
What is the Face Value of Alankit Ltd?
The Face Value of Alankit Ltd is 1.00.